|
1 Basic Principles of Nuclear Medicine |
|
|
1 | (12) |
|
1.1 Nuclear Medicine and Molecular Imaging |
|
|
1 | (1) |
|
1.2 Historical Background |
|
|
2 | (2) |
|
1.3 Scientific Basis of Nuclear Medicine |
|
|
4 | (3) |
|
|
4 | (1) |
|
|
5 | (1) |
|
|
5 | (1) |
|
1.3.4 Radiopharmaceuticals |
|
|
6 | (1) |
|
1.4 Technical Principles of Nuclear Medicine |
|
|
7 | (2) |
|
1.5 Scope of Nuclear Medicine |
|
|
9 | (1) |
|
1.5.1 Diagnostic Nuclear Medicine |
|
|
9 | (1) |
|
1.5.2 Therapeutic Nuclear Medicine |
|
|
10 | (1) |
|
|
10 | (1) |
|
|
11 | (2) |
|
2 Nuclear Medicine in the Genitourinary System |
|
|
13 | (18) |
|
|
13 | (1) |
|
|
13 | (1) |
|
2.3 Dynamic Renal Scintigraphy |
|
|
14 | (8) |
|
|
14 | (1) |
|
2.3.2 Renovascular Hypertension |
|
|
14 | (2) |
|
2.3.3 Urinary Tract Obstruction |
|
|
16 | (2) |
|
2.3.4 Evaluation of Renal Transplant Complications |
|
|
18 | (4) |
|
2.4 Cortical Renal Scintigraphy |
|
|
22 | (3) |
|
|
22 | (1) |
|
2.4.2 Urinary Tract Infection |
|
|
22 | (3) |
|
2.5 Vesicoureteral Reflux Study |
|
|
25 | (1) |
|
2.6 Testicular Imaging Study |
|
|
26 | (2) |
|
|
28 | (1) |
|
|
29 | (2) |
|
3 Nuclear Medicine in the Digestive System |
|
|
31 | (18) |
|
|
31 | (1) |
|
3.2 Clinical Applications |
|
|
31 | (1) |
|
3.3 Evaluation of Esophageal Transit Time |
|
|
31 | (1) |
|
3.4 Detection of Gastroesophageal Reflux |
|
|
32 | (1) |
|
3.5 Evaluation of Gastric Emptying |
|
|
32 | (3) |
|
3.6 Lower Gastrointestinal Bleeding Localization |
|
|
35 | (1) |
|
3.7 Diagnosis of Meckel's Diverticulum |
|
|
36 | (1) |
|
3.8 Diagnosis and Follow-Up of Inflammatory Bowel Disease |
|
|
37 | (2) |
|
3.9 Diagnosis of Hepatic Hemangioma |
|
|
39 | (1) |
|
3.10 Diagnosis of Hepatobiliary Diseases |
|
|
40 | (4) |
|
3.10.1 Diagnosis of Acute Cholecystitis |
|
|
40 | (1) |
|
3.10.2 Diagnosis of Common Bile Duct Obstruction |
|
|
41 | (1) |
|
3.10.3 Evaluation of Neonatal Hyperbilirubinemia |
|
|
42 | (1) |
|
3.10.4 Diagnosis of Hypokinesis Syndrome |
|
|
42 | (1) |
|
3.10.5 Evaluation of Complications After Hepatobiliary Surgery and Liver Transplantation |
|
|
42 | (2) |
|
|
44 | (2) |
|
3.12 Scintigraphic Nonimaging Procedures |
|
|
46 | (1) |
|
3.12.1 Carbon-14 Breath Tests |
|
|
46 | (1) |
|
|
46 | (1) |
|
|
46 | (3) |
|
4 Nuclear Medicine in the Endocrine System |
|
|
49 | (18) |
|
|
49 | (1) |
|
|
49 | (9) |
|
4.2.1 Clinical Applications |
|
|
49 | (1) |
|
4.2.2 Thyroid Imaging Study |
|
|
50 | (3) |
|
4.2.3 Thyroid Uptake Measurement |
|
|
53 | (5) |
|
|
58 | (3) |
|
4.3.1 Clinical Applications |
|
|
58 | (1) |
|
4.3.2 Preoperative Parathyroid Localization |
|
|
59 | (2) |
|
4.3.3 Intraoperative Parathyroid Localization |
|
|
61 | (1) |
|
|
61 | (4) |
|
4.4.1 Clinical Applications |
|
|
61 | (1) |
|
4.4.2 Adrenal Cortex Disorders |
|
|
61 | (1) |
|
4.4.3 Adrenal Medulla Disorders |
|
|
62 | (3) |
|
|
65 | (1) |
|
|
66 | (1) |
|
5 Nuclear Medicine in Soft-Tissue Infection and Inflammation |
|
|
67 | (12) |
|
|
67 | (1) |
|
5.2 Clinical Applications |
|
|
68 | (1) |
|
5.3 Diagnosis of Infection |
|
|
68 | (2) |
|
5.4 Imaging of Soft-Tissue Infections |
|
|
70 | (6) |
|
5.4.1 Localizing Signs Present |
|
|
70 | (4) |
|
5.4.2 No Localizing Signs Present |
|
|
74 | (2) |
|
|
76 | (1) |
|
|
76 | (1) |
|
|
77 | (2) |
|
6 Nuclear Medicine in the Respiratory System |
|
|
79 | (12) |
|
|
79 | (1) |
|
6.2 Clinical Applications |
|
|
79 | (1) |
|
6.3 Diagnosis of Pulmonary Embolism |
|
|
80 | (1) |
|
6.4 Pulmonary Sarcoidosis |
|
|
80 | (3) |
|
6.5 Idiopathic Pulmonary Fibrosis |
|
|
83 | (2) |
|
6.6 Pneumocystis carinii (jirovecii) Pneumonia |
|
|
85 | (1) |
|
6.7 Alveolar Permeability |
|
|
85 | (1) |
|
|
85 | (4) |
|
6.9 Preoperative Quantitative Ventilation/Perfusion Studies |
|
|
89 | (1) |
|
|
89 | (1) |
|
|
89 | (2) |
|
7 Nuclear Medicine in the Musculoskeletal System |
|
|
91 | (24) |
|
|
91 | (2) |
|
7.2 Clinical Applications |
|
|
93 | (1) |
|
7.2.1 Non-neoplastic Diseases |
|
|
93 | (1) |
|
7.2.2 Neoplastic Diseases |
|
|
93 | (1) |
|
7.3 Non-neoplastic Disease |
|
|
94 | (11) |
|
7.3.1 Imaging of Skeletal Infections |
|
|
94 | (4) |
|
7.3.2 Avascular Necrosis (Osteonecrosis) |
|
|
98 | (1) |
|
7.3.3 Trauma and Related Conditions |
|
|
98 | (6) |
|
7.3.4 Metabolic Bone Diseases |
|
|
104 | (1) |
|
7.4 Diagnosis of Neoplastic Bone Disease |
|
|
105 | (6) |
|
7.4.1 Imaging of Primary Bone Tumors |
|
|
106 | (2) |
|
7.4.2 Imaging of Metastatic Bone Disease |
|
|
108 | (3) |
|
|
111 | (2) |
|
|
113 | (2) |
|
8 Nuclear Medicine in the Cardiovascular System |
|
|
115 | (10) |
|
|
115 | (1) |
|
8.2 Clinical Applications |
|
|
115 | (1) |
|
8.3 Evaluation of Cardiac Function |
|
|
116 | (1) |
|
8.4 Evaluation of Myocardial Perfusion and Metabolism |
|
|
116 | (6) |
|
|
118 | (1) |
|
|
119 | (1) |
|
8.4.3 Follow-Up After Acute Myocardial Infarction |
|
|
120 | (1) |
|
8.4.4 Follow-Up After Revascularization Procedures |
|
|
120 | (1) |
|
8.4.5 Preoperative Evaluation |
|
|
121 | (1) |
|
8.4.6 Viability Assessment |
|
|
121 | (1) |
|
8.5 Soft-Tissue Hemangioma Study |
|
|
122 | (1) |
|
|
122 | (1) |
|
|
123 | (1) |
|
|
123 | (2) |
|
9 Nuclear Medicine in the Nervous System |
|
|
125 | (10) |
|
|
125 | (1) |
|
9.2 Clinical Applications |
|
|
125 | (1) |
|
|
125 | (2) |
|
|
127 | (1) |
|
|
128 | (1) |
|
|
129 | (1) |
|
|
130 | (2) |
|
9.8 Cerebrospinal Fluid Abnormalities |
|
|
132 | (1) |
|
|
133 | (1) |
|
|
134 | (1) |
|
10 Nuclear Medicine in Oncology |
|
|
135 | (12) |
|
|
135 | (1) |
|
10.2 Clinical Indications |
|
|
136 | (1) |
|
|
136 | (2) |
|
10.4 Staging of Malignant Disease |
|
|
138 | (1) |
|
10.5 Detection of Residual or Recurrent Disease |
|
|
139 | (1) |
|
10.6 Evaluating Response to Therapy |
|
|
140 | (2) |
|
10.7 Radiotherapy Planning |
|
|
142 | (1) |
|
10.8 Sentinel Lymph Node Localization |
|
|
143 | (1) |
|
|
143 | (1) |
|
|
144 | (3) |
|
11 Therapeutic Applications of Nuclear Medicine |
|
|
147 | (10) |
|
|
147 | (1) |
|
|
148 | (1) |
|
11.3 Treatment of Hyperthyroidism and Other Benign Thyroid Conditions |
|
|
148 | (1) |
|
11.4 Treatment of Differentiated Thyroid Cancer |
|
|
149 | (1) |
|
11.5 Treatment of Pain Secondary to Skeletal Metastases |
|
|
150 | (1) |
|
11.6 Treatment of Neuroendocrine Tumors |
|
|
150 | (1) |
|
11.7 Treatment of Prostatic Cancer |
|
|
151 | (1) |
|
|
151 | (1) |
|
11.9 Radionuclide Synovectomy |
|
|
152 | (1) |
|
11.10 Peptide Receptor Radionuclide Therapy |
|
|
153 | (1) |
|
11.11 Treatment of Hepatocellular Carcinoma and Liver Metastases |
|
|
154 | (1) |
|
|
154 | (1) |
|
|
154 | (3) |
Glossary |
|
157 | |